Cargando…
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
Stress is a ubiquitous risk factor for the exacerbation and development of affective disorders including major depression and posttraumatic stress disorder. Understanding the neurobiological mechanisms conferring resilience to the adverse consequences of stress could have broad implications for the...
Autores principales: | Bluett, Rebecca J., Báldi, Rita, Haymer, Andre, Gaulden, Andrew D., Hartley, Nolan D., Parrish, Walker P., Baechle, Jordan, Marcus, David J., Mardam-Bey, Ramzi, Shonesy, Brian C., Uddin, Md. Jashim, Marnett, Lawrence J., Mackie, Ken, Colbran, Roger J., Winder, Danny G., Patel, Sachin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379055/ https://www.ncbi.nlm.nih.gov/pubmed/28348378 http://dx.doi.org/10.1038/ncomms14782 |
Ejemplares similares
-
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
por: Hermanson, Daniel J., et al.
Publicado: (2013) -
CaMKII is a novel regulator of diacylglycerol lipase-α and striatal endocannabinoid signaling
por: Shonesy, Brian C., et al.
Publicado: (2013) -
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018) -
Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice
por: Cavener, Victoria S., et al.
Publicado: (2018) -
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
por: Bluett, R J, et al.
Publicado: (2014)